Programme

HKT
Virtual
  • 19:00
  • 19:10
  • 19:20
  • 19:30
  • 19:40
  • 19:50
  • 20:00
  • 20:10
Virtual
AASLD-IDDF- HKASLD Joint Symposium – Hot Topics in Chronic Hepatitis B
Virtual
19:00-20:05
19:00
Welcome remarks and introduction
19:05
Debate: Patients who are on antiviral therapy for chronic hepatitis B and have low HCC risk scores can stop HCC screening
19:35
Does peginterferon have a role in HBV cure programs?
19:50
Will new HBV biomarkers help us select agents to cure HBV?
** Programme is subject to change without prior notice